First Page | Document Content | |
---|---|---|
Anatomy Health Von Willebrand disease Coagulation Desmopressin Factor VII Adverse drug reaction Moroctocog alfa Haemophilia Coagulation system Medicine | Baxter Regulatory Master TemplateAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 511,10 KBShare Document on Facebook |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1qHpD - View Document | |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1q38M - View Document | |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1pMmB - View Document | |
13307 FT Factor VII plasma deficientDocID: 1mVEV - View Document | |
UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •DocID: 1kAcN - View Document |